Association of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean population

Journal of Rheumatology

Volumn 40, Issue 3, 2013, Pages 316-322

  Kim, Seong Kyu ^a   Kim, Seong Ho ^a   Nah, Seong Su ^a   Hyun Lee, Ji ^a   Hong, Seung Jae ^a   Kim, Hyun Sook ^a   Lee, Hye Soon ^a   Kim, Hyoun Ah ^a   Joung, Chung Il ^a   Bae, Jisuk ^a   Choe, Jung Yoon ^a   Lee, Shin Seok ^a  

^a not available

Author keywords

Fibromyalgia; Guanosine triphosphate cyclohydrolase 1; Nitric oxide; Pain; Polymorphism

Indexed keywords

GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; FIBROMYALGIA; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE 1 GENE; HAPLOTYPE; HUMAN; KOREAN; MAJOR CLINICAL STUDY; MALE; NOCICEPTION; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84874817045     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120929     Document Type: Article

References (39)

1. Thony B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 2000;347:1-16.
2. Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H, et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 2006;12:1269-77.
3. Costigan M, Befort K, Karchewski L, Griffin RS, D'Urso D, Allchorne A, et al. Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. BMC Neurosci 2002;3:16.
4. Tegeder I, Adolph J, Schmidt H, Woolf CJ, Geisslinger G, Lötsch J. Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype. Eur J Pain 2008;12:1069-77.
5. Campbell CM, Edwards RR, Carmona C, Uhart M, Wand G, Carteret A, et al. Polymorphisms in the GTP cyclohydrolase gene (GCH1) are associated with ratings of capsaicin pain. Pain 2009;141:114-8.
6. Kim H, Dionne RA. Lack of influence of GTP cyclohydrolase gene (GCH1) variations on pain sensitivity in humans. Mol Pain 2007;3:6.
7. Lazarev M, Lamb J, Barmada MM, Dai F, Anderson MA, Max MB, et al. Does the pain-protective GTP cyclohydrolase haplotype significantly alter the pattern or severity of pain in humans with chronic pancreatitis? Mol Pain 2008;4:58.
8. Holliday KL, Nicholl BI, Macfarlane GJ, Thomson W, Davies KA, McBeth J. Do genetic predictors of pain sensitivity associate with persistent widespread pain? Mol Pain 2009;5:56.
9. Bennett R. Fibromyalgia, chronic fatigue syndrome, and myofascial pain. Curr Opin Rheumatol 1998;10:95-103.
10. Bradley LA. Pathophysiology of fibromyalgia. Am J Med 2009;122:S22-30.
11. Kigwell BA. Nitric oxide-mediated metabolic regulation during exercise: Effect of training in health and cardiovascular disease. FASEB J 2000;14:1685-96.
12. Akyol O, Zoroglu SS, Armutcu F, Sahin S, Gurel A. Nitric oxide as a physiopathological factor in neuropsychiatric disorders. In Vivo 2004;18:377-90.
13. Larson AA, Giovengo SL, Russell IJ, Michalek JE. Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: Implications for nitric oxide pathways. Pain 2000;87:201-11.
14. Sendur OF, Turan Y, Tastaban E, Yenisey C, Serter M. Serum antioxidants and nitric oxide levels in fibromyalgia: A controlled study. Rheumatol Int 2009;29:629-33.
15. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DI, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-70.
16. Okifuji A, Turk DC, Sinclair JD, Starz TW, Marcus DA. A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome. J Rheumatol 1997; 24:377-83.
17. Kim YA, Lee SS, Park K. Validation of a Korean version of the Fibromyalgia Impact Questionnaire. J Korean Med Sci 2002;17:220-4.
18. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, et al. The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory. Cancer 1999; 85:1186-96.
19. Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the Beck Depression Inventory. Psychopathology 1998;31:160-8.
20. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
21. Kim JT, Shin DG. A standardization study of State-Trait Anxiety Inventory in Korea. N Med J 1978;21:1223-9.
22. Stephens M, Smith NJ, Donnelly P. A new method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
23. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73:1162-9.
24. Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Krüger M, Schoeps P, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 1999;42:2482-8.
25. Cohen H, Buskila D, Neumann L, Ebstein RP. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum 2002;46:845-7.
26. Gürsoy S, Erdal E, Herken H, Madenci E, Alaşehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 2003;23:104-7.
27. Buskila D, Cohen H, Neumann L, Ebstein RP. An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry 2004;9:730-1.
28. Russell IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35:550-6.
29. Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593-601.
30. Garthwaite J, Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 1995;57:683-706.
31. Meller ST, Pechman PS, Gebhart GF, Maves TJ. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience 1992;50:7-10.
32. Eisinger J, Gandolfo C, Zakarian H, Ayavou T. Reactive oxygen species, antioxidant status and fibromyalgia. J Musculoskelet Pain 1997;5:5-15.
33. Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yidizhan H. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: Etiologic and therapeutic concerns. Rheumatol Int 2006;26:598-603.
34. Kim DH, Dai F, Belfer I, Banco RJ, Martha JF, Tighiouart H, et al. Polymorphic variation of the guanosine triphosphate cyclohydrolase 1 gene predicts outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. Spine 2010;35:1909-14.
35. Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, et al. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 1999;6:433-9.
36. Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH. Cytokines play an aetiopathogenetic role in fibromyalgia: A hypothesis and pilot study. Rheumatology 2001;40:743-9.
37. Wang H, Moser M, Schiltenwolf M, Buchner M. Circulating cytokine levels compared to pain in patients with fibromyalgia - A prospective longitudinal study over 6 months. J Rheumatol 2008;35:1366-70.
38. Kim SK, Kim KS, Lee YS, Park SH, Choe JY. Arterial stiffness and proinflammatory cytokines in fibromyalgia syndrome. Clin Exp Rheumatol 2010;6 Suppl 63:S71-7.
39. Laroux FS, Pavlick KP, Hines IN, Kawachi S, Harada H, Bharwani S, et al. Role of nitric oxide in inflammation. Acta Physiol Scand 2001;173:113-8.